The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials
Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases. 2002 Apr 15;34(8):1115-1121.
A prospective study of long-term antiretroviral adherence patterns and their impact on biologic outcomes for human immunodeficiency virus (HIV)-infected participants in 2 randomized, multicenter clinical trials. Results demonstrating that nonwhite race was associated with poorer adherence (P<.001), and older age was associated with better adherence (P<.001).
|
This item has not yet been rated
|
 |
View article abstract
|
